PATRICIA FERRO: Open Payments
NPI 1346006889 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 32 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,335 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $175 |
| Novo Nordisk Inc | 4 | $88 |
| SHIELD THERAPEUTICS INC | 1 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $60 |
| PFIZER INC. | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
Products named: BREZTRI, ACCRUFER, Kerendia, ELIQUIS, TRELEGY ELLIPTA, CAPLYTA, REXULTI, Wegovy.
Industry payments across PA — which companies pay providers there.
